Community/Retail

Just making sure that everybody has a seat at the table is the most important thing at PQA.

Research suggests that individuals receiving a vaccine, such as ones from AstraZeneca and Johnson & Johnson, were more vulnerable to infection by new variants.

PQA wants to expand the types of services covered and report on the results of the current examples that are profiled in the SDOH guide.

Taking multiple prescription drugs and supplements can be especially dangerous for individuals with cancer who are about to undergo therapy.

The challenges in pharmacy are really a lack of standardization.

When both the clinical criteria and genetic testing were combined, 6.6 familial hypercholesterolemia cases per 1000 individuals screened were found.

Dimetapp is for cold and cough.

Pharmacists are ideally positioned to screen patients for estimation aids and then refer them to services.

Using machine learning, they find patterns in electronic health record data to help ascertain which individuals likely have the condition.

How would you handle these patients' questions?

This month's generic product news features clarithromycin, sevelamer hydrochloride, and metronidazole.

Pharmacists are an important touch point for PQA, and they're starting small and thinking big.

Any antibiotic use was associated with higher rates of IBD, and the risk went up substantially with each course.

Linaclotide (Linzess) is indicated in adults for treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation.

CalmAid helps reduce stress and tension.

With the new approval, manufacturers believe 7000 new rings will be able to enter the supply chain and will be available to customers in the second and third quarters of 2022.

PQA is focused on actually testing the feasibility and implementation of some of these measures as concepts.

Dong Xu, PhD, MS, curators' distinguished professor at the University of Missouri College of Engineering, discusses how the use of artificial intelligence may help develop new drug therapies targeting multiple disease states.

Pet peeves are brought to you by The Sassy Pharmacist.

The study results support a hypothesis for a differentiated mechanism from risankizumab, the company says.

This month's Rx product news features empagliflozin, mitapivat, and RSVpreF.

Sacubitril/valsartan (Entresto)reduces the risk of hospitalization and death related to cardiovascular complications in patients with heart failure.

Investigators found that 51% of participants achieved sustained unresponsiveness to peanut after 18 months of treatment.

Sara Wettergreen, assistant professor in the department of Clinical Pharmacy, and Department of Family Medicine, at Skaggs School of Pharmacy and Pharmaceutical Sciences, on burnout and mental health concerns among pharmacy technicians

Without sufficient vitamin D exposure, bones can become thin, brittle, or misshapen; however, excessive amounts of vitamin D are toxic.

Dong Xu, PhD, MS, curators' distinguished professor at the University of Missouri College of Engineering, discusses how artificial intelligence is being used to develop new drug therapies for medical treatments targeting cancers and other diseases.

One example that has already been done in the past relates to understanding how to better measure insulin persistence.

This month's OTC Cases focuses on heartburn, pinworm infection, and food poisoning.

The FDA has approved abrocitinib tablets to treat adults with moderate-to-severe, refractory atopic dermatitis.

In patients already using analgesics for pain control, pharmacists need to address medication adherence for improved osteoarthritis symptom control.